UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Accuray Inc (ARAY)

Accuray Inc (ARAY)
2.28 x 9 2.32 x 30
Post-market by (Cboe BZX)
2.28 +0.05 (+2.24%) 02/13/25 [NASDAQ]
2.28 x 9 2.32 x 30
Post-market 2.30 +0.02 (+0.88%) 16:10 ET
Quote Overview for Thu, Feb 13th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.21
Day High
2.28
Open 2.25
Previous Close 2.23 2.23
Volume 766,100 766,100
Avg Vol 830,950 830,950
Stochastic %K 14.58% 14.58%
Weighted Alpha -19.09 -19.09
5-Day Change -0.41 (-15.24%) -0.41 (-15.24%)
52-Week Range 1.40 - 2.95 1.40 - 2.95
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 229,313
  • Shares Outstanding, K 102,831
  • Annual Sales, $ 446,550 K
  • Annual Income, $ -15,550 K
  • EBIT $ 5 M
  • EBITDA $ 12 M
  • 60-Month Beta 1.51
  • Price/Sales 0.53
  • Price/Cash Flow N/A
  • Price/Book 4.81

Options Overview Details

View History
  • Implied Volatility 62.23% ( -1.18%)
  • Historical Volatility 69.11%
  • IV Percentile 31%
  • IV Rank 8.63%
  • IV High 583.80% on 11/26/24
  • IV Low 12.97% on 06/10/24
  • Put/Call Vol Ratio 0.67
  • Today's Volume 5
  • Volume Avg (30-Day) 507
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 10,186
  • Open Int (30-Day) 7,908

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.01
  • Number of Estimates 2
  • High Estimate 0.01
  • Low Estimate -0.04
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +83.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.11 +8.31%
on 01/14/25
Period Open: 2.24
2.95 -22.71%
on 02/06/25
+0.04 (+1.79%)
since 01/13/25
3-Month
1.67 +36.53%
on 11/19/24
Period Open: 1.81
2.95 -22.71%
on 02/06/25
+0.47 (+25.97%)
since 11/13/24
52-Week
1.40 +62.86%
on 08/12/24
Period Open: 2.75
2.95 -22.71%
on 02/06/25
-0.47 (-17.09%)
since 02/13/24

Most Recent Stories

More News
Accuray: Fiscal Q2 Earnings Snapshot

Accuray: Fiscal Q2 Earnings Snapshot

ARAY : 2.28 (+2.24%)
Here's Why you Should Retain Nevro Stock in Your Portfolio Now

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its technological innovations and diversification plans regarding its product portfolio. The optimism, led by a solid third-quarter...

AXGN : 18.14 (+1.97%)
NVRO : 5.72 (unch)
ARAY : 2.28 (+2.24%)
MASI : 179.59 (+0.04%)
Here's Why You Should Add Glaukos Stock to Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial results and a robust product pipeline. However, stiff competition is a concern.Shares of this Zacks Rank #2 (Buy)...

AXGN : 18.14 (+1.97%)
ARAY : 2.28 (+2.24%)
MASI : 179.59 (+0.04%)
GKOS : 146.38 (+1.91%)
HealthEquity Stock Falls Despite Q3 Earnings and Revenue Beat

HealthEquity, Inc. HQY reported adjusted earnings per share (EPS) of 78 cents in third-quarter fiscal 2025, surpassing the Zacks Consensus Estimate by 9.86%. The bottom line improved 30% on a year-over-year...

AXGN : 18.14 (+1.97%)
HQY : 113.94 (-0.50%)
ARAY : 2.28 (+2.24%)
MASI : 179.59 (+0.04%)
Here's Why You Should Add Accuray Stock in Your Portfolio Now

Accuray Incorporated ARAY is well-poised for growth in the coming quarters, courtesy of continued robust demand for its products. The optimism, led by robust international performance in the first quarter...

AXGN : 18.14 (+1.97%)
ARAY : 2.28 (+2.24%)
MASI : 179.59 (+0.04%)
ANGO : 10.53 (+0.72%)
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

DENTSPLY SIRONA XRAY is well-poised for growth due to its robust product portfolio and continued focus on research and development. However, forex remains a concern.Shares of this Zacks Rank #3 (Hold)...

AXGN : 18.14 (+1.97%)
ARAY : 2.28 (+2.24%)
MASI : 179.59 (+0.04%)
XRAY : 18.77 (+2.18%)
Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Inari Medical, Inc. NARI is well poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency...

AXGN : 18.14 (+1.97%)
ARAY : 2.28 (+2.24%)
MASI : 179.59 (+0.04%)
NARI : 79.93 (+0.01%)
Accuray: Fiscal Q1 Earnings Snapshot

Accuray: Fiscal Q1 Earnings Snapshot

ARAY : 2.28 (+2.24%)
Accuray: Fiscal Q4 Earnings Snapshot

Accuray: Fiscal Q4 Earnings Snapshot

ARAY : 2.28 (+2.24%)
This Penny Stock Insider Just Bought 100K Shares

This insider scooped up 100k shares after penny stock ARAY sold off last month.

ARAY : 2.28 (+2.24%)

Business Summary

Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing...

See More

Key Turning Points

3rd Resistance Point 2.40
2nd Resistance Point 2.34
1st Resistance Point 2.31
Last Price 2.28
1st Support Level 2.22
2nd Support Level 2.16
3rd Support Level 2.13

See More

52-Week High 2.95
Fibonacci 61.8% 2.36
Last Price 2.28
Fibonacci 50% 2.17
Fibonacci 38.2% 1.99
52-Week Low 1.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Increase Profitable Opportunities with Barchart's Technical Opinion